Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)

NCT04227327 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Difficulties in patient recruitment

Conditions

Advanced Breast Cancer

Interventions

DRUG: Abemaciclib
DRUG: Aromatase Inhibitors

Sponsor

University of Milano Bicocca